Basil Ferenczi, MD

Basil Ferenczi, MD, is a board-certified urologist, specializing in urologic oncology and robotic surgery. Away from work, Dr. Ferenczi enjoys tennis, hiking, camping, skiing and spending time with family.

The conditions Dr. Ferenczi treats include:

• Kidney cancer
• Prostate cancer
• Bladder cancer
• Testicular cancer
• Kidney stones
• Enlarged prostate

• Ferenczi, Basil A., Chris Baliga, Pascale Akl, Alison Bradywood, Craig Blackmore, Michael Glenn, Donna Smith, Gary Kaplan, and John M. Corman. "Pre-procedural Covid-19 screening of asymptomatic patients: a model for protecting patients, community and staff during expansion of surgical care." NEJM Catalyst Innovations in Care Delivery 1, no. 3 (2020).
• Ferenczi, Basil A., Ron Ron Cheng, Adam Daily, Christian Kuhr, Kathleen Kobashi, and John M. Corman. "Pre-operative COVID-19 screening: a model to provide non-discretionary care for urologic patients." International braz j urol 47 (2021): 631-636.
• Kord, Eyal, Basil Ferenczi, Renzo G. DiNatale, Adam Daily, Hannah Koenig, Jason Frankel, Nathan Jung, John Paul Flores, and Christopher Porter. "Are high-risk prostate cancer patients being treated equally? The impact of PSA." In Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 4, pp. 204-e17. Elsevier, 2023.
• Ferenczi, Basil, Wai Lee, Jason Frankel, Christopher Porter, and John Corman. "Anti-Tobacco Advertising—Is Bladder Cancer Adequately Addressed?." Urology Practice 8, no. 4 (2021): 450-453.
• Stamm, Andrew, Basil Ferenczi, Christopher Porter, Paul Kozlowski, Ryan Donahue, and John Corman. "Impact of catheter size on pain and continence following robotic prostatectomy." The Canadian Journal of Urology 27, no. 5 (2020): 10363-10368.
• Ferenczi, Basil, Jason Frankel, Nathan Jung, Christopher Porter, and John Paul Flores. "Effect of PSA on equal treatment of high-risk patients." (2020): e17514-e17514.